Metric Snapshot
- Latest value
- $65,968
- Coverage range
- 01 Jan 2019 - 30 Sep 2025
- Fact rows
- 22
Shareable Research Card
EVOK - Evoke Pharma Inc Operating Lease, Liability, Current
This metric view shows EVOK - Evoke Pharma Inc operating lease, liability, current history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q3 2025
- Latest reported value
- $65,968
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Financial Metric Page
Evoke Pharma Inc: Operating Lease, Liability, Current
Latest period: Q3 2025. Period end: 30 Sep 2025. Units: USD. Frequency: quarterly.
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
What This Metric Tells You
- Shows the reported level of operating lease, liability, current over 01 Jan 2019 - 30 Sep 2025.
- Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
- Built from 22 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Operating Lease, Liability, Current levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | AMAZON COM INC (["amzn"]) | $12,655,000,000 | Instant - 31 Dec 2025 | Open AMAZON COM INC Operating Lease, Liability, Current |
| 2 | VERIZON COMMUNICATIONS INC (["vz"]) | $4,542,000,000 | Instant - 31 Dec 2025 | Open VERIZON COMMUNICATIONS INC Operating Lease, Liability, Current |
| 3 | T-Mobile US, Inc. (["tmus", "tmusi", "tmusl", "tmusz"]) | $3,814,000,000 | Instant - 31 Dec 2025 | Open T-Mobile US, Inc. Operating Lease, Liability, Current |
| 4 | AT&T INC. (["t", "tbb", "tpa", "tpc"]) | $3,581,000,000 | Instant - 31 Dec 2025 | Open AT&T INC. Operating Lease, Liability, Current |
| 5 | Alphabet Inc. (["googl", "goog"]) | $3,209,000,000 | Instant - 31 Dec 2025 | Open Alphabet Inc. Operating Lease, Liability, Current |
| 6 | ORACLE CORP (["orcl", "orclpd"]) | $2,798,000,000 | Instant - 28 Feb 2026 | Open ORACLE CORP Operating Lease, Liability, Current |
Metric Details
- Metric
- Operating Lease, Liability, Current (OperatingLeaseLiabilityCurrent)
- Taxonomy
- us-gaap
- Units tracked
- USD
- Frequency coverage
- quarterly
- History range
- 01 Jan 2019 - 30 Sep 2025
- Facts on this page
- 22
- Description
- Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)
Evoke Pharma Inc Quarterly Operating Lease, Liability, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | $65,968 | 30 Sep 2025 | 10-Q | 13 Nov 2025 | 2025 | Q3 | ||
| Q2 2025 | $63,769 | 30 Jun 2025 | 10-Q | 14 Aug 2025 | 2025 | Q2 | ||
| Q1 2025 | $61,625 | 31 Mar 2025 | 10-Q | 13 May 2025 | 2025 | Q1 | ||
| Q4 2024 | $59,533 | 31 Dec 2024 | 10-Q | 13 Nov 2025 | 2025 | Q3 | ||
| Q3 2023 | $13,370 | -$126,930 | -90% | 30 Sep 2023 | 10-K/A | 14 May 2024 | 2023 | FY |
| Q2 2023 | $52,842 | 30 Jun 2023 | 10-K/A | 14 May 2024 | 2023 | FY | ||
| Q1 2023 | $91,397 | 31 Mar 2023 | 10-Q | 15 May 2023 | 2023 | Q1 | ||
| Q4 2022 | $129,074 | +$116,646 | +939% | 31 Dec 2022 | 10-K/A | 14 May 2024 | 2023 | FY |
| Q3 2022 | $140,300 | +$91,183 | +186% | 30 Sep 2022 | 10-Q | 09 Nov 2022 | 2022 | Q3 |
| Q4 2021 | $12,428 | -$129,277 | -91% | 31 Dec 2021 | 10-K | 21 Mar 2023 | 2022 | FY |
| Q3 2021 | $49,117 | +$13,002 | +36% | 30 Sep 2021 | 10-Q | 10 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $84,933 | +$13,722 | +19% | 30 Jun 2021 | 10-Q | 12 Aug 2021 | 2021 | Q2 |
| Q1 2021 | $119,926 | +$14,574 | +14% | 31 Mar 2021 | 10-Q | 12 May 2021 | 2021 | Q1 |
| Q4 2020 | $141,705 | +$3,167 | +2.3% | 31 Dec 2020 | 10-K | 08 Mar 2022 | 2021 | FY |
| Q3 2020 | $36,115 | +$717 | +2% | 30 Sep 2020 | 10-Q | 10 Nov 2020 | 2020 | Q3 |
| Q2 2020 | $71,211 | +$1,416 | +2% | 30 Jun 2020 | 10-Q | 06 Aug 2020 | 2020 | Q2 |
| Q1 2020 | $105,352 | +$2,100 | +2% | 31 Mar 2020 | 10-Q | 12 May 2020 | 2020 | Q1 |
| Q4 2019 | $138,538 | +$2,538 | +1.9% | 31 Dec 2019 | 10-K | 11 Mar 2021 | 2020 | FY |
| Q3 2019 | $35,398 | 30 Sep 2019 | 10-Q | 07 Nov 2019 | 2019 | Q3 | ||
| Q2 2019 | $69,795 | 30 Jun 2019 | 10-Q | 08 Aug 2019 | 2019 | Q2 | ||
| Q1 2019 | $103,252 | 31 Mar 2019 | 10-Q | 08 May 2019 | 2019 | Q1 | ||
| Q4 2018 | $136,000 | 01 Jan 2019 | 10-K | 12 Mar 2020 | 2019 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.